ArticlePloS one2022

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.

T Susanna Meijer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.